Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina: Results From the TERISA Randomized Clinical Trial

Study Questions:

What is the efficacy of ranolazine on weekly angina frequency in subjects with type 2 diabetes, coronary artery disease, and chronic stable angina who remain symptomatic despite treatment with up to two antianginal agents?